Skip to main content
OpenTrials

Clinical trial condition

Polycythemia Vera

Explore clinical trials studying Polycythemia Vera. Study availability and eligibility vary by location and protocol.

207 public trials 35 recruiting studies
Refine in advanced search Browse all conditions

Polycythemia Vera trial results

Completed

Open Label Study of Single Agent Oral RG7388 in Patients With Polycythemia Vera and Essential Thrombocythemia

NCT02407080

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +12 more
Locations
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
  • Wake Forest University Baptist Medical Center Winston-Salem, North Carolina, United States
View Trial Details
Completed

A Two-part Study to Assess the Safety and Preliminary Efficacy of Givinostat in Patients With Polycythemia Vera

NCT01901432

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +12 more
Locations
  • CHU Amiens - Hôpital Sud Amiens, France
  • Hôpital Morvan - CHRU de Brest Brest, France
  • Hopital Saint Vincent de Paul - GHICL Lille Lille, France
  • Hôpital Saint-Louis (AP-HP), Centre Investigations Cliniques Paris, France
View all 25 locations
View Trial Details
Completed

Expanded Treatment Protocol (ETP) of Ruxolitinib in Patients With Polycythemia Vera Who Were Hydroxyurea Resistant or Intolerant and for Whom no Treatment Alternatives Was Available.

NCT02292446

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • Novartis Investigative Site Linz, Austria
  • Novartis Investigative Site Salzburg, Austria
  • Novartis Investigative Site Wels, Austria
  • Novartis Investigative Site Antwerp, Belgium
View all 65 locations
View Trial Details
Completed

Research Tissue Bank

NCT00666549

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +15 more
Locations
  • Palo Alto Medical Foundation Research Institute Palo Alto, California, United States
  • Weill Cornell University Washington D.C., District of Columbia, United States
  • University of Georgetown Washington D.C., District of Columbia, United States
  • University of Illinois at Chicago Chicago, Illinois, United States
View Trial Details
Completed

Sympathicomimetic Agonist in Patients With Myeloproliferative Neoplasms With JAK2-mutation

NCT02311569

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +14 more
Locations
  • Kantonsspital Aarau Aarau, Switzerland
  • Universitaetsspital-Basel Basel, Switzerland
  • Istituto Oncologico della Svizzera Italiana - Ospedale San Giovanni Bellinzona, Switzerland
  • Inselspital Bern Bern, Switzerland
View Trial Details

Related conditions